p-Tau 217 Blood Test – A clinically advanced blood-based biomarker assay designed for early and accurate detection of Alzheimer’s disease.
p-Tau 217 Blood Test is a clinically advanced blood-based biomarker assay designed for early and accurate detection of Alzheimer’s disease. It offers high sensitivity and specificity for tau pathology, enabling non-invasive diagnosis and improved patient stratification.
Compared to traditional CSF or imaging-based diagnostics, p-Tau blood testing provides greater accessibility, reduced procedural burden, and supports timely clinical intervention and optimized patient management.